Dutch biotech Fornix BioSciences said on Thursday it will sell its medical supplies unit Laprolan to Rochester Medical for 10.35 million euros ($13.5 million), largely completing the company's unwinding.
The sale completes a series of divestments Fornix launched early last year after it lost a...